Please use this identifier to cite or link to this item: https://repository.unej.ac.id/xmlui/handle/123456789/77242
Full metadata record
DC FieldValueLanguage
dc.contributor.authorLidya Ameliana-
dc.contributor.authorMonica Iwud-
dc.contributor.authorSelly Rio-
dc.date.accessioned2016-10-24T01:02:08Z-
dc.date.available2016-10-24T01:02:08Z-
dc.date.issued2016-10-24-
dc.identifier.isbn978-602-72333-0-0-
dc.identifier.urihttp://repository.unej.ac.id/handle/123456789/77242-
dc.descriptionProceeding The 1st International Conference on Pharmaceutics & Pharmaceutical Sciences Drug Deiivery Systems: From Drug-Discovery, Pre-formulaticn, Formulation and Technological Approaches for Poorly Soluble Drugs and Proteinen_US
dc.description.abstractTransdermal drug delivery system is an administration of a therapeutic agent in the form of patches or semisolids that deliver drugs through intact skin for systemic effect1. The advantages of transdermal drug delivery systems are to avoid of hepatic first pass metabolism, ability to discontinue administration by removal of the system, to controll drug delivery for a longer time than the usual gastrointestinal transit of oral dosage form3, to prevent irritation of the digestive tract8, improves patient compliance3. Transdermal drug delivery systems may prevent the drug from enzymatic reactions in the astrointestinal tract wall5en_US
dc.language.isoenen_US
dc.subjectMELOXICAM TRANSDERMALen_US
dc.subjectPOLYVINYLPYRROLIDONEen_US
dc.subjectETHYL CELLULOSEen_US
dc.titleDEVELOPMENT OF MELOXICAM TRANSDERMAL MATRIX TYPE PATCH USING POLYVINYLPYRROLIDONE, HYDROXYPROPYL METHYCELLULOSE, AND ETHYL CELLULOSE COMBINATIONen_US
dc.typeProsidingen_US
Appears in Collections:LSP-Conference Proceeding

Files in This Item:
File Description SizeFormat 
Lidya A.pdf6.93 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.